TreeFrog Presents Data from Its Parkinson’s Cell Therapy Program
TreeFrog Therapeutics, a cell therapy development company with its leading Parkinson's disease program, is presenting for the first time at...
TreeFrog Therapeutics, a cell therapy development company with its leading Parkinson's disease program, is presenting for the first time at...
Today, Ajinomoto Co., Inc. ("Ajinomoto Co.") (TSE: 2802) launched a new version of its StemFit™ iPSC expansion medium. The enhanced version...